SEARCH:   Advanced

Blood, 15 December 2008, Vol. 112, No. 13, pp. 4818-4823. Prepublished online as a Blood First Edition Paper on September 19, 2008; DOI 10.1182/blood-2008-07-165969. This Article Full Text Full Text (PDF) All Versions of this Article: blood-2008-07-165969v1 112/13/4818    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Martinelli, I. Articles by Mannucci, P. M. Search for Related Content PubMed PubMed Citation Articles by Martinelli, I. Articles by Mannucci, P. M. Related Collections Hemostasis, Thrombosis, and Vascular Biology How I Treat Free Research Articles Clinical Trials and Observations Related Articles in Blood Online Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  HOW I TREAT How I treat rare venous thromboses Ida Martinelli1, Massimo Franchini2, and Pier Mannuccio Mannucci1 1 Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Medicine and Medical Specialties, University of Milan and Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Milan; and 2 Immunohematology and Transfusion Centre, Department of Pathology and Laboratory Medicine, University Hospital of Parma, Parma, Italy Venous thromboembolism may involve venous sites other than the lower limbs, such as cerebral, splanchnic, and upper limb veins. Although uncommon, these thromboses may be clinically severe and challenging for caregivers. In this review, the main pathogenic, clinical, and therapeutic features of thromboses in rare venous sites are discussed. Even though there was a lot of recent progress in understanding the mechanistic role of inherited and acquired thrombophilia and of the interactions between different risk factors, the optimal management of these patients is still unsettled, being currently based on the consensus of experts due to the lack of randomized trials. The implementation of large interdisciplinary registries is a necessary weapon to optimize the treatment of rare venous diseases. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? Related Articles in Blood Online: Anticoagulants in portal vein thrombosis: don't be so shy! Laurent Spahr, Françoise Boehlen, Philippe de Moerloose, and Antoine Hadengue Blood 2009 113: 5031-5032. [Full Text] [PDF] Response: Anticoagulation in splanchnic vein thrombosis Ida Martinelli, Massimo Franchini, Massimo Primignani, and Pier M. Mannucci Blood 2009 113: 5032. [Full Text] [PDF] This article has been cited by other articles: L. Spahr, F. Boehlen, P. de Moerloose, and A. Hadengue Anticoagulants in portal vein thrombosis: don't be so shy! Blood, May 14, 2009; 113(20): 5031 - 5032. [Full Text] [PDF] I. Martinelli, M. Franchini, M. Primignani, and P. M. Mannucci Response: Anticoagulation in splanchnic vein thrombosis Blood, May 14, 2009; 113(20): 5032 - 5032. [Full Text] [PDF]

	Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020